Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Committee calls for GM insects
Grasshopper
The technology is believed to have the potential to help control diseases such as dengue and malaria.

Technology may have potential to help control diseases and pests

The House of Lords are calling on the Government to launch a field trial of genetically modified (GM) insects and make the most of the UK's status as a world leader in this area.

The technology is believed to have the potential to help control diseases such as dengue and malaria, by rendering insects unable to transmit disease.  This could potentially help almost half of the global population, who live in at-risk areas.

It is thought that GM technology could also reduce insect populations to minimise their threat to animals and crops, saving the world billions of pounds in the process.  

The call follows the publication of a report by the House of Lords Science and Technology Committee into Genetically Modified insects. In it, they state that GM insects have considerable potential to control insect-borne disease and agricultural pests, but they are no 'silver bullet'.

The report describes how the UK, a world leader in this area of research, could reap significant economic benefits. However, it says that EU regulation is 'failing lamentably'.

Commenting on the report, the Earl of Selborne, chairman of the House of Lords Science and Technology Committee, explains:

"GM insect technologies have the potential not only to save countless lives worldwide, but also to generate significant economic benefits for UK plc, where we are an acknowledged world leader. But the development of GM insect technologies has come to a screeching halt because the EU regulatory system is woefully inadequate. Until we can get a regulatory framework that will do justice to this area of scientific research, its wings are effectively clipped.

"Our report concludes that the UK Government has a moral duty to test the potential of this technology, for the long-term benefit of those countries where diseases like dengue and malaria are indiscriminate killers. So as a first step towards that goal, we urge the Government to initiate field trials to put not only the science but, crucially, the regulations to the test. This trial could also be a focus to increase public engagement in the area."

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.